Roche Introduces RocheDiabetes InsulinStart to Facilitate the Access to Insulin Therapy for T2D Patients

 Roche Introduces RocheDiabetes InsulinStart to Facilitate the Access to Insulin Therapy for T2D Patients

Roche Introduces RocheDiabetes InsulinStart to Facilitate the Access to Insulin Therapy for T2D Patients

Shots:

  • RocheDiabetes InsulinStart is a service designed to aid patients with T2D with a goal to facilitate the transition from oral antidiabetic therapies to long-term insulin once-daily therapy
  • The message-based service supports the patients in the critical phase of finding the optimal dose for insulin (qd). The service will provide the user with the text message in the morning to remind them to take a blood sugar test and in the evening to recommend the insulin dose
  • The Roche Diabetes InsulinStart service is offered in integration with Accu-Chek Smart Pix software, allowing doctors to adjust the therapy according to the patient’s need and avoids additional visit at the same time

Click here ­to­ read full press release/ article | Ref: Roche | Image: Finanzen

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post